At issue are expensive chemotherapy drugs that make the lower reimbursements inadequate to keep the clinics’ balance sheets solvent. As a result, some cancer patients on Medicare will need to seek treatment at other clinics and hospitals, according to the report.
More Articles on Medicare Reimbursements:
Hospitals Brace for Sizable Medicare Cuts From Sequestration
3 Years of PPACA: The 5 Biggest Changes in Healthcare Since the Law’s Passage
Congress Avoids Government Shutdown, Passes Budget With $2.7T in Healthcare Savings
Next Up in Financial Management
-
Optum is selling physician practice assets in New York to New Hyde Park-based Northwell Health and Valhalla-based Westchester Medical Center,…
-
Baylor Scott & White Health Plan will eliminate prior authorization requirements for all in-network inpatient services and more than 80%…
-
President Donald Trump’s administration is reshaping leadership across several federal agencies that oversee healthcare research, spending and regulation. The NIH…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.